Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. (Q38125769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

title

Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

James Doecke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

William Wilson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Alan Rembach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

Tim M Ryan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

Andrew D Watt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

Kevin J Barnham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

Colin L Masters

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

published in

Biomarkers in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

641-662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

The projected effect of risk factor reduction on Alzheimer's disease prevalence

6 March 2020

cites work

1 reference

2012 Alzheimer's disease facts and figures

21 January 2018

1 reference

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease

21 January 2018

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

Biological Markers of Alzheimer’s Disease

21 January 2018

1 reference

Identifying and validating biomarkers for Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

21 January 2018

1 reference

Safety and acceptability of the research lumbar puncture

21 January 2018

1 reference

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

21 January 2018

1 reference

Alzheimer disease and platelets: how's that relevant

21 January 2018

1 reference

Proteome-based plasma biomarkers for Alzheimer's disease

21 January 2018

1 reference

Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display

21 January 2018

1 reference

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer′s Disease

21 January 2018

1 reference

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease

21 January 2018

1 reference

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease

21 January 2018

1 reference

High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity.

21 January 2018

1 reference

21 January 2018

Blood-related proteomics

1 reference

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

21 January 2018

1 reference

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

21 January 2018

1 reference

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

21 January 2018

1 reference

Alzheimer's disease: a central role for amyloid

21 January 2018

1 reference

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

21 January 2018

1 reference

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

21 January 2018

1 reference

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease

21 January 2018

1 reference

Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.

21 January 2018

1 reference

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels

21 January 2018

1 reference

The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43).

21 January 2018

1 reference

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

21 January 2018

1 reference

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

21 January 2018

1 reference

Plasma ß-amyloid and cognitive decline

21 January 2018

1 reference

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study

21 January 2018

1 reference

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

21 January 2018

1 reference

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

21 January 2018

1 reference

Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

Change in plasma Aß peptides and onset of dementia in adults with Down syndrome

21 January 2018

1 reference

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

21 January 2018

1 reference

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

21 January 2018

1 reference

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

21 January 2018

1 reference

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

21 January 2018

1 reference

21 January 2018

1 reference

Serum creatinine levels correlate with plasma amyloid Beta protein

21 January 2018

1 reference

White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke

21 January 2018

1 reference

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

21 January 2018

1 reference

Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophy

21 January 2018

1 reference

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

21 January 2018

1 reference

Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease

21 January 2018

1 reference

Amyloid β levels in human red blood cells

21 January 2018

1 reference

Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanisms

21 January 2018

1 reference

Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

21 January 2018

1 reference

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

21 January 2018

1 reference

Membrane lipids in the aging human brain

21 January 2018

1 reference

Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.

21 January 2018

1 reference

The challenge of lipid rafts

21 January 2018

1 reference

Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling

21 January 2018

1 reference

Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease

21 January 2018

1 reference

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

Regulated proteolysis of APP and ApoE receptors

21 January 2018

1 reference

Isoform-specific proteolysis of apolipoprotein-E in the brain

21 January 2018

1 reference

Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease

21 January 2018

1 reference

Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease

21 January 2018

1 reference

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease

21 January 2018

1 reference

Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.

21 January 2018

1 reference

Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses

21 January 2018

1 reference

Cholesterol homeostasis and function in neurons of the central nervous system

21 January 2018

1 reference

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

21 January 2018

1 reference

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment

21 January 2018

1 reference

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

21 January 2018

1 reference

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

21 January 2018

1 reference

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study

21 January 2018

1 reference

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology

21 January 2018

1 reference

Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding

21 January 2018

1 reference

Oxysterols as markers of neurological disease--a review

21 January 2018

1 reference

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

21 January 2018

1 reference

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

Deregulation of sphingolipid metabolism in Alzheimer's disease

21 January 2018

1 reference

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

21 January 2018

1 reference

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

21 January 2018

1 reference

Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

21 January 2018

1 reference

Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry

21 January 2018

1 reference

Concentration and origin of choline in the rat brain

21 January 2018

1 reference

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

Evidence for a membrane defect in Alzheimer disease brain

21 January 2018

1 reference

Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease

21 January 2018

1 reference

Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease

21 January 2018

1 reference

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

21 January 2018

1 reference

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

21 January 2018

1 reference

Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia

21 January 2018

1 reference

Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients

21 January 2018

1 reference

The neurobiology of isoprostanes and Alzheimer's disease

21 January 2018

1 reference

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.

21 January 2018

1 reference

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

21 January 2018

1 reference

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease

21 January 2018

1 reference

Gene expression profiling in human neurodegenerative disease

21 January 2018

1 reference

Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression

21 January 2018

1 reference

Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?

21 January 2018

1 reference

Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes

21 January 2018

1 reference

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

21 January 2018

1 reference

Plasma microRNA biomarkers for detection of mild cognitive impairment

21 January 2018

1 reference

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress

21 January 2018

1 reference

Copper, iron and zinc in Alzheimer's disease senile plaques

21 January 2018

1 reference

Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease

21 January 2018

1 reference

Therapeutics for Alzheimer's disease based on the metal hypothesis

21 January 2018

1 reference

Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis

21 January 2018

1 reference

Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron

21 January 2018

1 reference

Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts

21 January 2018

1 reference

Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice

21 January 2018

1 reference

Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities

21 January 2018

1 reference

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

21 January 2018

1 reference

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

21 January 2018

1 reference

Trace elements and cognitive impairment: an elderly cohort study.

21 January 2018

1 reference

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

21 January 2018

1 reference

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

21 January 2018

1 reference

Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate.

21 January 2018

1 reference

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.

21 January 2018

1 reference

Serum aluminum levels in Alzheimer's disease and other senile dementias.

21 January 2018

1 reference

Elevation of serum copper levels in Alzheimer's disease

21 January 2018

1 reference

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

21 January 2018

1 reference

Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia.

21 January 2018

1 reference

Excess of serum copper not related to ceruloplasmin in Alzheimer disease.

21 January 2018

1 reference

'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function

21 January 2018

1 reference

Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives

21 January 2018

1 reference

A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

21 January 2018

1 reference

Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD.

21 January 2018

1 reference

The role of copper in inflammatory disorders

21 January 2018

1 reference

Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease

21 January 2018

1 reference

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability

21 January 2018

1 reference

Subclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease

21 January 2018

1 reference

Elevated cortical zinc in Alzheimer disease

21 January 2018

1 reference

Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid

21 January 2018

1 reference

Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?

21 January 2018

1 reference

Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease?

21 January 2018

1 reference

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

Inflammation in neurodegenerative disease--a double-edged sword

21 January 2018

1 reference

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Systemic inflammation and Alzheimer's disease

21 January 2018

1 reference

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer

21 January 2018

1 reference

The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease.

21 January 2018

1 reference

Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population

21 January 2018

1 reference

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes

21 January 2018

1 reference

A meta-analysis of cytokines in Alzheimer's disease

21 January 2018

1 reference

Peripheral cytokines and chemokines in Alzheimer's disease

21 January 2018

1 reference

Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

21 January 2018

1 reference

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

21 January 2018

1 reference

Identification of oxidized plasma proteins in Alzheimer's disease

21 January 2018

1 reference

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

21 January 2018

1 reference

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

Clusterin: a forgotten player in Alzheimer's disease

21 January 2018

1 reference

Nuclear clusterin is associated with neuronal apoptosis in the developing rat brain upon ethanol exposure

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

Genome-wide analysis of genetic loci associated with Alzheimer disease

21 January 2018

1 reference

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

Plasma clusterin and the risk of Alzheimer disease

21 January 2018

1 reference

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

21 January 2018

1 reference

No diagnostic value of plasma clusterin in Alzheimer's disease

21 January 2018

1 reference

Thrombin accumulation in brains of patients with Alzheimer's disease

21 January 2018

1 reference

Serine proteases and their serpin inhibitors in Alzheimer's disease

21 January 2018

1 reference

Thrombin, a mediator of neurotoxicity and memory impairment

21 January 2018

1 reference

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.

21 January 2018

1 reference

Mining biomarkers in human sera using proteomic tools

21 January 2018

1 reference

Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology

21 January 2018

1 reference

Proteomic research in psychiatry

21 January 2018

1 reference

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

21 January 2018

1 reference

Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.

21 January 2018

1 reference

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset

21 January 2018

1 reference

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

Plasma biomarkers of Alzheimer's disease

21 January 2018

1 reference

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.

21 January 2018

1 reference

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease

21 January 2018

1 reference

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

21 January 2018

1 reference

Blood-based protein biomarkers for diagnosis of Alzheimer disease

21 January 2018

1 reference

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

21 January 2018

1 reference

Plasma biomarkers for Alzheimer's disease: much needed but tough to find

21 January 2018

1 reference

From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay

21 January 2018

1 reference

Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study

21 January 2018

1 reference

Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease

21 January 2018

1 reference

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

21 January 2018

1 reference

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.13.59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23905901 AND SRC:MED&resulttype=core&format=json

release_sws4q5zf25ggdbmw2dwwegldfq

6 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sws4q5zf25ggdbmw2dwwegldfq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference